Goldman Sachs Group Inc Twist Bioscience Corp Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
A detailed history of Goldman Sachs Group Inc transactions in Twist Bioscience Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 478,863 shares of TWST stock, worth $20.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
478,863
Previous 733,546
34.72%
Holding current value
$20.1 Million
Previous $27 Million
39.24%
% of portfolio
0.0%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding TWST
# of Institutions
252Shares Held
65.9MCall Options Held
247KPut Options Held
203K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.94MShares$291 Million1.7% of portfolio
-
Black Rock Inc. New York, NY5.77MShares$242 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.46MShares$229 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.64MShares$194 Million0.25% of portfolio
-
Jpmorgan Chase & CO New York, NY3.61MShares$151 Million0.01% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.36B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...